PIPA5116940

SARS-CoV-2 3CLpro Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5116940-Each-of-1 In Stock ₹ 46,858.50

PIPA5116940 - Each of 1

₹ 46,858.50

In Stock

Quantity

1

Base Price: ₹ 46,858.50

GST (18%): ₹ 8,434.53

Total Price: ₹ 55,293.03

Antigen

SARS-CoV-2 3CLpro

Classification

Polyclonal

Conjugate

Unconjugated

Gene Alias

Coronavirus; COVID; COVID 19; COVID-19; SARS Coronavirus; SARS CoV; SARS CoV2; SARS-CoV-2

Immunogen

Recombinant fusion protein containing a sequence corresponding to amino acids 1-306 of coronavirus 3CLpro (YP_0097252951)

Quantity

100 μL

Primary or Secondary

Primary

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Applications

Immunocytochemistry, Western Blot

Concentration

0.24 mg/mL

Formulation

PBS with 50% glycerol and 0.01% thimerosal; pH 7.3

Host Species

Rabbit

Purification Method

Affinity chromatography

Regulatory Status

RUO

Target Species

Virus

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5116915

--

Img

Thermo Scientific

PIPA5116941

--

Img

Thermo Scientific

PIPA5116951

--

Img

Thermo Scientific

PIPA5116917

--

Img

Thermo Scientific

PIPA5116946

--

Img

Thermo Scientific

PIPA5117070

--

Img

Thermo Scientific

PIPA5114451

--

Img

Thermo Scientific

PIPA5116929

--

Description

  • Positive Samples: 293T Immunogen sequence: MESLVPGFNE KTHVQLSLPV LQVRDVLVRG FGDSVEEVLS EARQHLKDGT CGLVEVEKGV LPQLEQPYVF IKRSDARTAP HGHVMVELVA ELEGIQYGRS GETLGVLVPH VGEIPVAYRK VLLRKNGNKG AGGHSYGADL KSFDLGDELG TDPYEDFQEN WNTKHSSGVT RELMRELNGG AYTRYVDNNF CGPDGYPLEC IKDLLARAGK ASCTLSEQLD FIDTKRGVYC CREHEHEIAW YTERSEKSYE LQTPFEIKLA KKFDTFNGEC PNFVFPLNSI IKTIQPRVEK KKLDGFMGRI RSVYPV Severe Acute Respiratory Syndrome (SARS), an emerging disease characterized by atypical pneumonia, has been attributed to a novel coronavirus (SARS-CoV)
  • The SARS 3C-like protease (SARS 3CL (pro)) is a cysteine protease engaging in the proteolytic cleavage of the viral precursor polyprotein to a series of functional proteins required for corona virus replication and is considered an attractive target for therapeutics against SARS.